Alternative splicing of p53 and p73: the novel p53 splice variant p53delta is an independent prognostic marker in ovarian cancer.
about
Uncovering the role of p53 splice variants in human malignancy: a clinical perspectivep53 Proteoforms and Intrinsic Disorder: An Illustration of the Protein Structure-Function Continuum ConceptCoiled-coil domain containing 68 (CCDC68) demonstrates a tumor-suppressive role in pancreatic ductal adenocarcinoma.A novel BMX variant promotes tumor cell growth and migration in lung adenocarcinoma.p53 Isoforms: An Intracellular Microprocessor?Splice variants of zinc finger protein 695 mRNA associated to ovarian cancer.Oncomorphic TP53 Mutations in Gynecologic Cancers Lose the Normal Protein:Protein Interactions with the microRNA Microprocessing ComplexThe relative mRNA expression of p53 isoforms in breast cancer is associated with clinical features and outcome.Expression of TP53 isoforms p53β or p53γ enhances chemosensitivity in TP53(null) cell lines.TP53 oncomorphic mutations predict resistance to platinum‑ and taxane‑based standard chemotherapy in patients diagnosed with advanced serous ovarian carcinoma.p53 Family: Role of Protein Isoforms in Human Cancer.Biological functions of p53 isoforms through evolution: lessons from animal and cellular models.A novel TFF2 splice variant (∆EX2TFF2) correlates with longer overall survival time in cholangiocarcinoma.Mechanisms, function and clinical applications of DNp73.GT198 Splice Variants Display Dominant-Negative Activities and Are Induced by Inactivating MutationsThe consequence of oncomorphic TP53 mutations in ovarian cancer.Aberrant splicing of the DMP1-ARF-MDM2-p53 pathway in cancerDamage-inducible intragenic demethylation of the human TP53 tumor suppressor gene is associated with transcription from an alternative intronic promoter.Thousands of exon skipping events differentiate among splicing patterns in sixteen human tissues.Alternative splicing in cancer: implications for biology and therapy.p53 regulates cytoskeleton remodeling to suppress tumor progression.p53 Isoforms: Key Regulators of the Cell Fate Decision.p53 suppresses CCL2-induced subcutaneous tumor xenograft.Differential effects of diverse p53 isoforms on TAp73 transcriptional activity and apoptosis.p53 is an important regulator of CCL2 gene expression.Role of Δ133p53 isoform in NF-κB inhibitor PDTC-mediated growth inhibition of MKN45 gastric cancer cellsSequence-dependent cooperative binding of p53 to DNA targets and its relationship to the structural properties of the DNA targets.Identification of nonsense-mediated mRNA decay pathway as a critical regulator of p53 isoform β.Discovery of TP53 splice variants in two novel papillary urothelial cancer cell lines.High expression of the p53 isoform γ is associated with reduced progression-free survival in uterine serous carcinoma.p53 Isoforms and Their Implications in CancerIdentification of a novel splice variant of the human musashi-1 gene
P2860
Q27015641-201F63BF-560A-425D-B736-04A0126321DEQ28079390-9963DA10-8993-43A3-BD97-74CE814A7189Q30831639-CA89EE83-FA12-49C5-85F9-3606014A5FB5Q33779499-44CCEB43-F5B6-49AE-98F4-750FF98CC829Q34202703-1A19A1FE-ADA1-439B-872A-89F44A00FBDDQ34368827-C4309FBC-604C-4E3D-8496-5564FA04850CQ34373621-235CCC67-BEBD-4FDE-8C5B-8B0BA5C1A323Q34391735-EA593520-D89F-4A80-AF57-7C0CF8289667Q34586799-C73894E2-A98B-4354-B33B-D37409549018Q34775855-FA8C5D33-406E-4B58-819C-2DC9B334554EQ35326348-14747663-47A1-4B7F-9116-27BF3594FFD0Q35546335-161DDE69-BA15-4075-969E-CFBAEE131A73Q36642338-CCF2DF84-0CE2-4D5C-A3FD-0EF8F6E05975Q37075900-8CA7D914-F2E8-45D4-BF43-A746F801A5BDQ37094568-E8090FF2-3C9C-4114-9335-C88E81209654Q37225303-5FF15C82-DA49-43E8-9ABE-1CA1CCE7AF46Q37306546-7DACF339-E442-405F-A2F7-B353C76C8098Q37418067-2DC1B29B-8575-4A29-98A3-DBB90DC6C54BQ37482993-7B58A634-300E-477C-94E9-2D6AC14C686FQ38179828-B20B06A1-D43C-4291-87BA-4401BB355C72Q38553239-214FE513-7A6A-429A-A99F-21019412AC5AQ38708506-8FCA345E-9CBA-4AE7-A789-18B60458C777Q38930310-D01B2189-9573-430C-9670-D93AB15860F4Q39236844-0DB4AB75-3832-4D13-A5C3-5249A97695E8Q39313206-9679B3BD-297B-4B6D-9996-238AC61C2333Q42160338-08877315-5C1A-45A7-B6F5-8C8EBFEDB96CQ42701104-D034C01B-EA43-44A5-8FE6-32E5CF43AA8CQ47131765-A34CFA18-A764-4FA2-A5E0-568E7094D39FQ52827232-838A2363-1B8A-4F75-B32E-617912F6C216Q55452619-E1059B42-9B35-48CB-AA73-CB659FFA604EQ58702684-556B4B80-4452-4F2D-BBF5-EA84C5B740FFQ58784185-FF24896A-4C3E-4D68-9E40-4ADF127C1C0B
P2860
Alternative splicing of p53 and p73: the novel p53 splice variant p53delta is an independent prognostic marker in ovarian cancer.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh-hant
name
Alternative splicing of p53 an ...... stic marker in ovarian cancer.
@en
Alternative splicing of p53 an ...... stic marker in ovarian cancer.
@nl
type
label
Alternative splicing of p53 an ...... stic marker in ovarian cancer.
@en
Alternative splicing of p53 an ...... stic marker in ovarian cancer.
@nl
prefLabel
Alternative splicing of p53 an ...... stic marker in ovarian cancer.
@en
Alternative splicing of p53 an ...... stic marker in ovarian cancer.
@nl
P2093
P2860
P356
P1433
P1476
Alternative splicing of p53 an ...... stic marker in ovarian cancer.
@en
P2093
A G Zeimet
E Schuster
G Daxenbichler
G Hofstetter
P2860
P2888
P304
P356
10.1038/ONC.2009.482
P407
P577
2010-01-18T00:00:00Z
P5875
P6179
1013548801